Advancing primary care with essential peer-reviewed research and insights into CNS disorders
Page 131
More Articles from The Primary Care Companion for DNS Disorders
Letter to the Editor
Nabilone and Dementia-Associated Sexual Inhibition
February 19, 2015
A variety of pharmacologic interventions have been utilized to manage behavioral and psychological symptoms of dementia. Is nabilone an effective treatment option for agitation and sexual disinhibition, which are…
Article
Evaluation of Changes in Citalopram Prescribing Patterns Following a US Food and Drug Administration Alert: A Retrospective Cohort Study
February 12, 2015
The US Food and Drug Administration (FDA) issued a warning stating that patients older than 60 years are not recommended to receive doses of citalopram exceeding 20 mg daily…
Article
Incidence and Timing of Taper/Posttherapy-Emergent Adverse Events Following Discontinuation of Desvenlafaxine 50 mg/d in Patients With Major Depressive Disorder
February 5, 2015
Here, review results from a post hoc analysis that evaluated the tolerability of long-term desvenlafaxine for major depressive disorder at discontinuation using a taper regimen compared with abrupt discontinuation.Â
Article
Depression and Anxiety Following Early Pregnancy Loss: Recommendations for Primary Care Providers
January 29, 2015
Emotional distress usually follows early pregnancy loss. This reaction tends to improve over time, but women should be screened for depression and anxiety in case a formal evaluation and…
Brief Report
The Role of Pharmacogenetic Testing in the Amelioration of Antidepressant-Related Motor Disturbances in 2 Young Adult Men With Major Depressive Disorder
January 8, 2015
Two young men with depressive symptoms experienced severe motor disturbances while taking SSRIs. Both patients had a long history of medication failures and complex presentations. Genetic testing of the…
